Guangdong Marubi Biotechnology Hits Day Low Amid Price Pressure at CNY 30.42

Guangdong Marubi Biotechnology Co., Ltd. experienced a notable decline today, with the stock dropping by 4.06% on February 24, 2026. The stock reached an intraday low of CNY 30.42, reflecting ongoing challenges in its market performance. Over the past week, the stock has seen a decrease of 6.36%, contrasting with a slight gain of 0.41% in the China Shanghai Composite index. In terms of longer-term performance, Guangdong Marubi has faced consistent underperformance, with a 10.51% decline over the past month and a significant 45.89% drop over the last five years. The company's market capitalization stands at CNY 12,483 million, categorizing it as a large-cap entity within the fast-moving consumer goods (FMCG) sector. Despite a return on equity of 9.86% and a price-to-book ratio of 3.76, the stock's performance metrics indicate a challenging environment. The company has reported a high dividend yield of 2.41%, but its net sales growth has been modest at an annual rate of 14.97%, while operating profit has declined by 6.64% over the past five years.